Experiences with
Meronem97 public posts
Want to take advantage of all our features? Just log in!
or
Sweet's syndrome triggered by erlotinib
Sweet syndrome induced by epidermal growth factor receptor (EGFR) inhibitors, 2022.
A case of Sweet's syndrome triggered by erlotinib, an epidermal growth factor receptor inhibitor.
"Epidermal growth factor receptor inhibitors are associated with multiple cutaneous toxicities, with PRIDE (papulo-pustules